Clinical Trials Browser

Terminated × Gliosarcoma × Panitumumab × Clear all

NCT01017653 2013-09-04

Panitumumab and Irinotecan for Malignant Gliomas

Phase 2 Terminated

16 enrolled 9 charts

Glioblastoma, Glioma, Gliosarcoma